glp 1 discontinuation rates Obesity treatment just cleared a major barrier: an oral pill that matches near-injectable weight loss numbers. Aleniglipron, a once-daily oral GLP-1 receptor agonist from Structure Therapeutics, produced a 16.3% placebo-adjusted weight loss High Discontinuation Rates of GLP-1

Appetite Dysregulation Menopause can alter hunger and fullness signaling at the hypothalamic level

But the trajectory is clear: we are entering a new era where the boundaries between metabolic medicine and addiction treatment are blurring and thats a good thing

30

Their long duration of diabetes suggests that these patients would have minimal insulin secretion capacity remaining and, therefore, it will be of interest to see the glycemic reductions stratified by duration, with the expectation that those with shorter duration will experience better glycemic improvement

However, the effects depend on continued use and when you stop, your body gradually returns to its natural baseline

[6] Muttenthaler M, et al